The biology and pharmacology of calcium channel alpha2-delta proteins Pfizer Satellite Symposium to the 2003 Society for Neuroscience Meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003.
Taylor
Charles P
CP
D000085:Acetates / Q000378:metabolism / Q000494:pharmacology; D000588:Amines; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001665:Binding Sites; D015220:Calcium Channels / Q000378:metabolism* / Q000494:pharmacology*; D020746:Calcium Channels, L-Type; D003509:Cyclohexanecarboxylic Acids; D004195:Disease Models, Animal; D000077206:Gabapentin; D006801:Humans; D051379:Mice; D000069583:Pregabalin; D051381:Rats; D012958:Societies, Scientific; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology
D000085:Acetates; D000588:Amines; D000700:Analgesics; D000927:Anticonvulsants; C425903:CACNA2D1 protein, human; C486060:Cacna2d1 protein, rat; C486058:Cacna2d2 protein, mouse; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D003509:Cyclohexanecarboxylic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin